Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1066 | 964 | 1089 | 1134 | 1301 | 1902 |
Fund Return | 6.58% | -3.56% | 8.94% | 4.29% | 5.4% | 6.64% |
Place in category | 1777 | 1878 | 1653 | 1581 | 1253 | 711 |
% in Category | 88 | 90 | 82 | 88 | 84 | 77 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 128.68B | 33.31 | 15.72 | 14.41 | ||
Lansforsakringar USA Indexnara | 52.03B | 41.52 | 19.01 | 17.59 | ||
Lansforsakringar Sverige Indexnara | 36.23B | 9.89 | 1.26 | 9.17 | ||
Lansforsakringar Global Hallbar B | 25.69B | 33.55 | 13.71 | 13.09 | ||
Lansforsakringar Global Hallbar A | 25.69B | 33.18 | 13.38 | 12.82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SPP Aktiefond Europa | 18.07B | 15.05 | 10.88 | 9.08 | ||
Swedbank Robur Access Europa | 14.73B | 14.08 | 10.61 | 9.01 | ||
Handelsbanken European Index utd | 12.87B | 12.51 | 9.22 | 8.25 | ||
Handelsbanken Europafond Index | 12.87B | 12.51 | 9.21 | 8.73 | ||
Lansforsakringar Europa Indexnara | 11.22B | 11.27 | 8.94 | 8.49 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 3.25 | 688.00 | -0.29% | |
Novo Nordisk B | DK0062498333 | 3.03 | 637.5 | -0.20% | |
Novartis | CH0012005267 | 3.01 | 89.02 | +0.36% | |
FinecoBank | IT0000072170 | 3.00 | 16.6500 | -1.48% | |
KBC Groep | BE0003565737 | 2.99 | 74.40 | -0.08% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review